mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.03 |